Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2016 Dec 5;35:190. doi: 10.1186/s13046-016-0466-0

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s). 2016

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

PMC Copyright notice

Fig. 1 — Association of high expression of CCDC88A with a poor outcome in PDAC patients. a, b. Immunohistochemical staining of PDAC tissues using anti-CCDC88A antibody. CCDC88A staining was present in the cytoplasm (a) and in the basolateral portions (b) of tumor cells. Arrows, CCDC88A localized basolaterally. Magnifications: ×200. c, d. Kaplan-Meier analysis of (c) PDAC-specific survival and (d) overall survival according to CCDC88A expression. e. ROC curve of 102 PDAC cases for analysis of the impact of the total immunohistochemical score of CCDC88A on prognosis